within Pharmacolibrary.Drugs.ATC.S;

model S01AX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.005,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Bibrocathol is an antiseptic agent derived from bismuth used primarily as an ophthalmic preparation for the treatment of mild conjunctivitis and blepharitis. It has antimicrobial and astringent properties. Bibrocathol is not approved in the United States but is used in Europe, mainly in Germany, as an over-the-counter ophthalmic remedy.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or measured pharmacokinetic parameters for bibrocathol in humans have been identified in the literature, likely due to its topical (ocular) use and negligible systemic absorption.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01AX05;
